Table 2.
Comparison of measured parameters between healthy group and basal cell carcinoma (BCC) group
| Parameter | Control group | BCC group | P | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| n | Median | Q1; Q3 | Min. | Max. | n | Median | Q1; Q3 | Min. | Max. | ||
| Cathelicidin (pg/ml) | 58 | 613.4 | 443.1; 938.1 | 185.7 | 6355.4 | 49 | 1702.9 | 615.9; 2617.8 | 168.1 | 6778.9 | < 0.001 |
| HBD 1 (ng/ml) | 7 | 52.1 | 36.9; 59.0 | 34.8 | 125.6 | 5 | 53.8 | 41.8; 68.8 | 39.8 | 87.8 | – |
| HBD 2 (ng/ml) | 53 | 0.48 | 0.31; 0.83 | 0.16 | 8.06 | 47 | 3.12 | 0.62; 5.69 | 0.18 | 8.89 | < 0.001 |
BCC – basal cell carcinoma, HBD – human β-defensin, Q1, Q3 – quartiles